Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Hicks, David G
4318  Ergebnisse:
Personensuche X
?
1

In ER-Positive, HER2-Negative Breast Cancers, HER2 mRNA Lev..:

Tyburski, Haley ; Karakas, Cansu ; Finkelman, Brian S....
Laboratory Investigation.  104 (2024)  3 - p. 100309 , 2024
Link: https://doi.org/10.1016/..
 
?
2

HER2 evaluation for clinical decision making in human solid..:

Zhang, Huina ; Finkelman, Brian S ; Ettel, Mark G...
Histopathology.  85 (2024)  1 - p. 3-19 , 2024
Link: https://doi.org/10.1111/..
 
?
3

Performance of HER2 DAKO HercepTest and Ventana 4B5 immunoh..:

Navarro Sanchez, Janira M. ; Finkelman, Brian S. ; Tyburski, Haley...
Human Pathology.  148 (2024)  - p. 51-59 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Breast Cancer With HER2 Immunohistochemical Score 2 and Ave..:

Ajabnoor, Rana ; Zhang, Gloria ; Hu, Yan...
Modern Pathology.  37 (2024)  8 - p. 100530 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Validation and interpretation of Pan-TRK immunohistochemist..:

Karakas, Cansu ; Giampoli, Ellen J. ; Love, Tanzy..
Diagnostic Pathology.  19 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
6

Best practices for achieving consensus in HER2‐low expressi..:

Tozbikian, Gary ; Bui, Marilyn M. ; Hicks, David G...
Histopathology.  85 (2024)  3 - p. 489-502 , 2024
Link: https://doi.org/10.1111/..
 
?
7

Interobserver and Interantibody Reproducibility of HER2 Imm..:

Karakas, Cansu ; Tyburski, Haley ; Turner, Bradley M...
American Journal of Clinical Pathology.  159 (2023)  5 - p. 484-491 , 2023
Link: https://doi.org/10.1093/..
 
?
8

The Evolution of Ki-67 and Breast Carcinoma: Past Observati..:

Finkelman, Brian S. ; Zhang, Huina ; Hicks, David G..
Cancers.  15 (2023)  3 - p. 808 , 2023
Link: https://doi.org/10.3390/..
 
?
9

Analytical and clinical validation of PATHWAY Anti-HER-2/ne..:

Garrido, Charo ; Manoogian, Melissa ; Ghambire, Dhiraj...
Virchows Archiv.  484 (2023)  6 - p. 1005-1014 , 2023
Link: https://doi.org/10.1007/..
 
?
10

The Rochester Modified Magee Algorithm (RoMMa): An Outcomes..:

Turner, Bradley M. ; Finkelman, Brian S. ; Hicks, David G....
Cancers.  15 (2023)  3 - p. 903 , 2023
Link: https://doi.org/10.3390/..
 
?
11

HER2 in uterine serous carcinoma: Current state and clinica..:

Navarro Sanchez, Janira M ; Finkelman, Brian S ; Turner, Bradley M...
American Journal of Clinical Pathology.  , 2023
Link: https://doi.org/10.1093/..
 
?
12

Exploration of HER2 (ERBB2) immunohistochemistry in non-sma..:

Cardillo, Anthony B. ; Kovar, Sierra ; Roper, Nitin..
Annals of Medicine & Surgery.  85 (2023)  6 - p. 2640-2646 , 2023
Link: https://doi.org/10.1097/..
 
?
13

HER2 categorical changes after neoadjuvant chemotherapy: A ..:

Karakas, Cansu ; Tyburski, Haley ; Turner, Bradley M....
Human Pathology.  142 (2023)  - p. 34-41 , 2023
Link: https://doi.org/10.1016/..
 
?
14

The histopathology of skeletal metastases:

, In: Bone Cancer,
Turner, Bradley M. ; Hicks, David G. - p. 771-782 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Predictive Biomarkers in Breast Cancer: ER, PR, and HER-2/N..:

, In: Handbook of Practical Immunohistochemistry,
Prichard, Jeffrey W. ; Mehr, Chelsea R. ; Hicks, David G.. - p. 293-312 , 2022
Link: https://doi.org/10.1007/..
 
1-15